Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible (PAZOPANIB-AML)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by University Hospital Muenster.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
University Hospital Muenster
ClinicalTrials.gov Identifier:
First received: May 17, 2011
Last updated: May 27, 2015
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)